The aim of a modern international study led by Nanyang Technological University in Singapore was to discover modern information about Asian physicians’ perceptions on the apply of artificial intelligence in healthcare.
RESULTS
The researchers surveyed 165 gastroenterologists and gastrointestinal surgeons from Singapore, China, Hong Kong and Taiwan. They received a questionnaire asking them to rate their level of agreement with statements designed to assess their trust, acceptance and risk perception of the apply of artificial intelligence in gastroenterology. The questionnaire provided three different scenarios in which artificial intelligence could emerge applied – detection, characterization and intervention.
Based on Results published in the scientific journal JMIR (Journal of Medical Internet Research) AI, approximately eight out of 10 respondents said they accepted and trusted the apply of artificial intelligence in the diagnosis and assessment of colorectal polyps. About 70% said they accepted and trusted AI-powered tools to remove polyps, and about 80% said they accepted and trusted AI to characterize polyps.
While no differences in acceptance levels were found between public and private practices, as well as between vast hospitals and diminutive group practices, years of experience may be an indicator of trust in AI, the researchers noted. The study found that gastroenterologists with less than a decade of clinical experience perceive greater risks associated with using AI-based tools than their more experienced counterparts.
“Greater clinical experience in the treatment of colorectal polyps among senior gastroenterologists may have given these clinicians greater confidence in their medical knowledge and practice, and thus generated greater confidence in maintaining clinical discretion after the introduction of new technologies” – Joseph Sung, professor at NTU and one of – explained the study’s co-authors.
Prof. Sung also believes that juvenile gastroenterology doctors likely view AI as risky, given the lack of confidence in using it for invasive procedures such as polyp removal.
A BIGGER TREND
Wilson Goh, an assistant professor at NTU Lee Kong Chian School of Medicine who led the study, said they focused on gastroenterology specialists because of their “intensive use of image-based diagnosis and surgical or endoscopic interventions.”
This is evident in the increasing availability of AI-based tools, software and decision support systems for the diagnosis and treatment of gastrointestinal disorders across Asia.
Japanese companies, AI medical service (AIM) and NEC are well-known AI developers in the field of diagnostic endoscopy. AIM is out now cooperates with the Stanford University Medical School to verify your product. Chinese startup The vision of artificial intelligence also offers AI-based, CE marked polyp detection software called EndoScreener.
Meanwhile, Asian universities and hospitals, including: Chinese University of Hong KongThailand Chulalongkorn Universityand the National University Hospital of Singapore have built artificial intelligence-based endoscopic systems that support detect, diagnose and remove cancer in the gastrointestinal tract.